MaxCyte regains Nasdaq compliance after stock price recovery
MaxCyte received notice on June 10, 2026, from Nasdaq that the company has regained compliance with the minimum bid price requirement under Listing Rule…
$1.0010 consecutive business days30 consecutive trading days